Cyclerion Therapeutics Inc (CYCN)
2.98
-0.07
(-2.30%)
USD |
NASDAQ |
Apr 24, 11:23
Cyclerion Therapeutics Price to Book Value: 0.7155 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 0.7323 |
| April 22, 2024 | 0.7323 |
| April 19, 2024 | 0.8403 |
| April 18, 2024 | 0.7726 |
| April 17, 2024 | 0.7726 |
| April 16, 2024 | 0.7635 |
| April 15, 2024 | 0.7971 |
| April 12, 2024 | 0.8091 |
| April 11, 2024 | 0.7322 |
| April 10, 2024 | 0.7443 |
| April 09, 2024 | 0.7227 |
| April 08, 2024 | 0.7683 |
| April 05, 2024 | 0.7923 |
| April 04, 2024 | 0.8139 |
| April 03, 2024 | 0.7587 |
| April 02, 2024 | 0.7587 |
| April 01, 2024 | 0.7371 |
| March 28, 2024 | 0.7683 |
| March 27, 2024 | 0.7395 |
| March 26, 2024 | 0.7395 |
| March 25, 2024 | 0.7275 |
| March 22, 2024 | 0.7323 |
| March 21, 2024 | 0.7683 |
| March 20, 2024 | 0.7923 |
| March 19, 2024 | 0.7443 |
| Date | Value |
|---|---|
| March 18, 2024 | 0.7683 |
| March 15, 2024 | 0.7803 |
| March 14, 2024 | 0.8067 |
| March 13, 2024 | 0.7227 |
| March 12, 2024 | 0.7203 |
| March 11, 2024 | 0.7447 |
| March 08, 2024 | 0.7515 |
| March 07, 2024 | 0.7443 |
| March 06, 2024 | 0.6722 |
| March 05, 2024 | 0.6959 |
| March 04, 2024 | 0.7683 |
| March 01, 2024 | 0.7599 |
| February 29, 2024 | 0.7203 |
| February 28, 2024 | 0.6817 |
| February 27, 2024 | 0.6422 |
| February 26, 2024 | 0.6356 |
| February 23, 2024 | 0.6389 |
| February 22, 2024 | 0.6905 |
| February 21, 2024 | 0.6247 |
| February 20, 2024 | 0.6269 |
| February 16, 2024 | 0.6354 |
| February 15, 2024 | 0.6337 |
| February 14, 2024 | 0.6313 |
| February 13, 2024 | 0.6937 |
| February 12, 2024 | 0.8022 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3628
Minimum
Nov 15 2023
4.812
Maximum
Mar 31 2023
1.675
Average
1.601
Median
Aug 10 2023
Price to Book Value Benchmarks
| Eli Lilly and Co | 64.53 |
| iBio Inc | 0.7046 |
| AbbVie Inc | 28.68 |
| Agile Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.668 |
Price to Book Value Related Metrics
| PS Ratio | 13.00 |
| Price | 2.98 |
| Earnings Yield | -101.0% |
| Market Cap | 8.076M |